Twist Bioscience Corporation
TWST
$47.66
-$1.98-3.99%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 18.59% | 20.32% | 22.72% | 25.30% | 25.85% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.59% | 20.32% | 22.72% | 25.30% | 25.85% |
| Cost of Revenue | 3.53% | 3.31% | 4.73% | 8.22% | 8.60% |
| Gross Profit | 37.30% | 43.24% | 49.12% | 52.80% | 56.81% |
| SG&A Expenses | 17.50% | 13.08% | 11.15% | 13.81% | 10.73% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.54% | 4.90% | 4.77% | 7.52% | 5.62% |
| Operating Income | 17.76% | 22.54% | 23.65% | 18.27% | 20.26% |
| Income Before Tax | 61.53% | 63.03% | 61.42% | 0.26% | 3.83% |
| Income Tax Expenses | 63.13% | 28.57% | -15.44% | -57.57% | -55.10% |
| Earnings from Continuing Operations | 61.19% | 62.79% | 61.33% | 0.52% | 4.13% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 61.19% | 62.79% | 61.33% | 0.52% | 4.13% |
| EBIT | 17.76% | 22.54% | 23.65% | 18.27% | 20.26% |
| EBITDA | 17.38% | 22.07% | 22.28% | 17.15% | 21.29% |
| EPS Basic | 62.54% | 63.81% | 62.11% | 2.75% | 6.07% |
| Normalized Basic EPS | 20.56% | 25.27% | 24.21% | 19.05% | 21.84% |
| EPS Diluted | 62.26% | 63.55% | 61.82% | 2.71% | 6.03% |
| Normalized Diluted EPS | 20.91% | 25.60% | 24.52% | 19.05% | 21.84% |
| Average Basic Shares Outstanding | 3.21% | 3.13% | 2.89% | 2.58% | 2.21% |
| Average Diluted Shares Outstanding | 3.71% | 3.63% | 3.39% | 2.58% | 2.21% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |